FDA Approves New Alzheimer’s Drug From Biogen

The US Food and Drug Administration (FDA) approved Biogen’s Alzheimer’s drug. This latest application comes 20 years after the last time an Alzheimer’s drug sought approval. As a result, the market cheered on the new drug and sent Biogen’s stock surging more than 38%. 

Read more on TheCapitalist.com